Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rinvoq. Always confirm against the full prescribing information.
100 interactions
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Upadacitinib.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Upadacitinib.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Upadacitinib.
Level 1 evidence
Apalutamide
The metabolism of Upadacitinib can be increased when combined with Apalutamide.
Level 1 evidence
Aprepitant
The metabolism of Upadacitinib can be decreased when combined with Aprepitant.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Upadacitinib.
Level 2 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Upadacitinib.
Level 1 evidence
Bacillus calmette-guerin substrain tice live antigen
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Upadacitinib.
Level 1 evidence
Berotralstat
The metabolism of Upadacitinib can be decreased when combined with Berotralstat.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Upadacitinib.
Level 2 evidence
Carbamazepine
The metabolism of Upadacitinib can be increased when combined with Carbamazepine.
Level 1 evidence
Cenobamate
The serum concentration of Upadacitinib can be decreased when it is combined with Cenobamate.
Level 1 evidence
Enter your NPI to unlock 68 major interactions for Rinvoq
Rinvoq (Upadacitinib) has 350 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Rinvoq (Upadacitinib) has 206 major, 107 moderate, and 37 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rinvoq. Always confirm against the full prescribing information.